I am a Chief Operating Officer with over 30 years of experience in the pharmaceutical and medical device industries.I am a seasoned executive and consultant who specializes in mergers and acquisitions, business/commercial operations, and regulatory compliance.My most notable accomplishments include:Drove $25M+ P&L growth by optimizing global operations and leading strategic initiatives in regulated manufacturing.Managed $2M+ M&A pipeline for healthcare markets in MENA and SE Asia, driving merger readiness and post-merger integration.Saved $495K by negotiating key contracts and optimizing sourcing strategies in new product introductions.Drove 30% sales growth in one year by launching a veterinary and animal health product portfolio and expanding market reach.Led a $5M joint venture in China, becoming the world’s second-largest natural fragrance chemical producer with a 3-year payback.I specialize in advising clients on strategic direction, valuation, due diligence, and post-merger integration. I leverage my extensive industry knowledge, network, and negotiation skills to identify and pursue growth opportunities, mitigate risks, and optimize outcomes.As COO of HydroAir Global, I lead the commercialization of patented Poly-Hexidine™ technology, a polymer additive that kills bacteria, fungi, and viruses, including Covid-19, for medical devices, nonwoven fabrics, and textiles.As the Director of Pharmaceutical & Medical Device M&A at Equalsten, I advise clients on strategic direction, valuation, due diligence, and post-merger integration. I leverage my extensive industry knowledge, network, and negotiation skills to identify and pursue growth opportunities, mitigate risks, and optimize outcomes.I am passionate about creating innovative and effective solutions for infection prevention and public health.Let’s connect so we can talk through how I can leverage my experience to help you with creating a strategic direction and solutions that will move your organization forward.